Literature DB >> 18025455

PET sheds light on Alzheimer's disease genetic risk.

Russell H Swerdlow1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18025455      PMCID： PMC2141875          DOI： 10.1073/pnas.0709690104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

Review 1.  Mitochondria in Alzheimer's disease.

Authors:  Russell H Swerdlow; Stephen J Kish
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

2.  Hippocampal hypometabolism predicts cognitive decline from normal aging.

Authors:  Lisa Mosconi; Susan De Santi; Juan Li; Wai Hon Tsui; Yi Li; Madhu Boppana; Eugene Laska; Henry Rusinek; Mony J de Leon
Journal:  Neurobiol Aging       Date:  2007-01-11       Impact factor: 4.673

3.  Family patterns of coronary heart disease mortality: the Framingham Longevity Study.

Authors:  F N Brand; D K Kiely; W B Kannel; R H Myers
Journal:  J Clin Epidemiol       Date:  1992-02       Impact factor: 6.437

Review 4.  Functional neuroimaging in Alzheimer's type dementia.

Authors:  Andreas K Demetriades
Journal:  J Neurol Sci       Date:  2002-11-15       Impact factor: 3.181

5.  Altered cerebral energy metabolism in Alzheimer's disease: a PET study.

Authors:  H Fukuyama; M Ogawa; H Yamauchi; S Yamaguchi; J Kimura; Y Yonekura; J Konishi
Journal:  J Nucl Med       Date:  1994-01       Impact factor: 10.057

6.  Cytochrome oxidase deficiency in Alzheimer's disease.

Authors:  W D Parker; C M Filley; J K Parks
Journal:  Neurology       Date:  1990-08       Impact factor: 9.910

7.  Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.

Authors:  Pinar E Coskun; M Flint Beal; Douglas C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

8.  Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.

Authors:  W D Parker; J K Parks
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

9.  Marked changes in mitochondrial DNA deletion levels in Alzheimer brains.

Authors:  M Corral-Debrinski; T Horton; M T Lott; J M Shoffner; A C McKee; M F Beal; B H Graham; D C Wallace
Journal:  Genomics       Date:  1994-09-15       Impact factor: 5.736

10.  Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.

Authors:  G W Small; J C Mazziotta; M T Collins; L R Baxter; M E Phelps; M A Mandelkern; A Kaplan; A La Rue; C F Adamson; L Chang
Journal:  JAMA       Date:  1995 Mar 22-29       Impact factor: 56.272
View more
  3 in total

1.  Association of parental dementia with cognitive and brain MRI measures in middle-aged adults.

Authors:  S Debette; P A Wolf; A Beiser; R Au; J J Himali; A Pikula; S Auerbach; C Decarli; S Seshadri
Journal:  Neurology       Date:  2009-12-09       Impact factor: 9.910

Review 2.  Hippocampal calcium dysregulation at the nexus of diabetes and brain aging.

Authors:  Olivier Thibault; Katie L Anderson; Chris DeMoll; Lawrence D Brewer; Philip W Landfield; Nada M Porter
Journal:  Eur J Pharmacol       Date:  2013-07-17       Impact factor: 4.432

3.  2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters.

Authors:  Julie L Wang; Ajit K Parhi; Shunichi Oya; Brian Lieberman; Mei-Ping Kung; Hank F Kung
Journal:  Nucl Med Biol       Date:  2008-05       Impact factor: 2.408
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.